(0.18%) 5 140.75 points
(0.19%) 38 515 points
(0.26%) 17 892 points
(-0.74%) $83.23
(1.87%) $1.959
(0.03%) $2 347.80
(0.01%) $27.54
(0.72%) $928.75
(-0.14%) $0.933
(-0.22%) $11.00
(-0.25%) $0.798
(1.07%) $92.86
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 5.40%
@ $0.976
Utstedt: 7 feb 2024 @ 21:19
Avkastning: 29.12%
Forrige signal: feb 7 - 19:02
Forrige signal:
Avkastning: -0.80 %
Live Chart Being Loaded With Signals
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally...
Stats | |
---|---|
Dagens volum | 1.85M |
Gjennomsnittsvolum | 8.91M |
Markedsverdi | 878.21M |
EPS | $0 ( 2024-02-27 ) |
Neste inntjeningsdato | ( $-0.0900 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -5.04 |
ATR14 | $0.00700 (0.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Yu Alice Lin-tsing | Buy | 0 | |
2024-03-28 | Paganelli John A | Buy | 0 | |
2024-03-28 | Lachman Prem A | Buy | 0 | |
2024-03-28 | Pfenniger Richard C Jr | Buy | 0 | |
2024-03-28 | Krasno Richard M | Buy | 0 |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 12 318 025 | Sell: 0 |
Volum Korrelasjon
OPKO Health Inc Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
OPKO Health Inc Korrelasjon - Valuta/Råvare
OPKO Health Inc Økonomi
Annual | 2023 |
Omsetning: | $863.50M |
Bruttogevinst: | $232.10M (26.88 %) |
EPS: | $-0.250 |
FY | 2023 |
Omsetning: | $863.50M |
Bruttogevinst: | $232.10M (26.88 %) |
EPS: | $-0.250 |
FY | 2022 |
Omsetning: | $1.00B |
Bruttogevinst: | $288.20M (28.70 %) |
EPS: | $-0.460 |
FY | 2021 |
Omsetning: | $1.77B |
Bruttogevinst: | $581.52M (32.77 %) |
EPS: | $-0.0500 |
Financial Reports:
No articles found.
OPKO Health Inc
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.